Ambiotis is the first Contract Research Organization (CRO) worldwide working on the active resolution of inflammation

THE NEW APPROACH TO INFLAMMATION

Perception of inflammation has changed: chronicity is not only a perpetual repetition of acute inflammation but is resulting from an inability to solve the inflammatory disorder.

Pioneer in the field of inflammation resolution, Ambiotis has now acquired 10 years of experience and built a strong expertise in both cell/animal models and analytical measurement. This combination is the key to ensure a thorough understanding of the finely tuned mechanisms of this biological process.

AN INNOVATIVE PLATFORM OF TECHNOLOGIES

Ambiotis proposes services adapted to pharmaceutical, dermo-cosmetic, agro- food/nutraceutical industries to evaluate the potential of their molecules at preclinical or clinical stages of development. The company thus helps them put faster on the market always more efficient and innovative compounds.

Perform the proof of concept

Approaches specific to each therapeutic area: arthritis, COPD, allergies, Crohn disease, colitis, obesity/diabetes, peritonitis…

Validate the efficacy of new actives

Approaches on cellular model or skin explants for a market-oriented positioning (cutaneous protection, anti-pollution, anti-aging, defence, fight against acne or other skin diseases)

Bring proof of efficacy

Biological evaluations for health ingredients to valorize an immuno-modulatory potential, prevent diseases and maintain an healthy balance

Decipher and validate mechanism of action in humans

A precise and quantitative monitoring of interest mediators in various human biological samples

Santé Animale

Animal Health

Valorize nutrition ingredients and veterinary products

Dedicated biological evaluations of products for a better animal health and well-being

« Our collaboration with Ambiotis started in 2018 and we have since collaborated on multiple occasions. The team is highly dynamic and efficient, and always does its best to answer our scientific problematic with high quality work. »

Laurent Garçon

Co-founder Nuvamid SA Lausanne – Switzerland

"We collaborated with Ambiotis to develop a new efficacy model surrounding inflammatory resolution, a model that was key in the development of a powerful and innovative active ingredient."

Nicolas Bechetoille, Research Manager Skin Biology

Gattefossé

"We are working with Ambiotis for a couple of years for specific cellular assays and appreciate very much their technical expertise and the resulting data quality. They are also interested and very open to discuss the science and optimize together the experiment design to make sure our goals are achieved in a clear and efficient manner. They are an uncomplicated preclinical partner which complements very well our own team."

Senior Research Scientist, Swiss biotech

In our collaboration with Ambiotis, we evaluated the effect of our product HE-100 on inflammation resolution. Ambiotis’s expertise in this field led to successful completion of our Research Program. The data were presented at the New York Academy of Sciences (NYAS) in June 2018 in a symposium titled: “Resolution of Inflammation, Infection and Tissue Regeneration”.

"As a global leader in plant-based ingredients for food, nutrition and health markets, we are committed to working in close collaboration with international experts. We really enjoyed working with Ambiotis to assess the anti-inflammatory properties of our products. We particularly appreciated the quality of the results and the respect of the deadlines."

Dr Damien Truffin

Toxicology expert

Most of all, we appreciated the quality of our scientific discussion on the study design, the customer support, and the follow-up and thoroughness of the results shared."

Kader THIAM

Senior VP Discovery & Preclinical Models at genOway